Search - tctmd.com

Displaying 381 - 400 of 528

Sort: Relevancy | Date

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

News Daily News

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Yael L. Maxwell

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

L.A. McKeown

October 11, 2013

News Daily News

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

L.A. McKeown

October 11, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Yael L. Maxwell

August 19, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

Advertisement

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content